MEDIA, Pa., April 10 /PRNewswire-FirstCall/ -- Synova Healthcare, Inc., a subsidiary of Synova Healthcare Group, Inc. , announced today that its soon-to-be-launched, over-the-counter vaginal infection test - Fem-V(TM), will be available at Happy Harry’s Pharmacy Chain starting in May. Fem-V(TM), cleared by the FDA for at-home use, is a non- invasive test developed to assist women in the diagnosis and appropriate treatment of vaginal infections.
“We are very pleased that Happy Harry’s shares our vision for this exciting new product,” stated company President Mr. David Harrison. “The introduction of Fem-V(TM) confirms their commitment to providing new and innovative healthcare products to their customers. Fem-V(TM) represents an important breakthrough in the diagnosis of the cause of vaginal infections, and will assist women in determining if they should see their healthcare provider before treating their vaginal infection with an over-the-counter medication.”
About Synova Healthcare Group, Inc.:
Synova Healthcare Group, Inc. (SNVH) presently operates two wholly owned subsidiaries: Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc. The company distributes rapid, non-invasive medical diagnostics to retail for over-the-counter (OTC) use, and directly to health care providers for point of care (POC) use in the clinical setting. The company’s products are designed to improve human health and quality of life by providing early and accurate awareness of the onset of certain medical conditions.
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “potential” and similar expressions. These statements reflect the Company’s current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance or achievements to differ materially from those expressed in or implied by such statements. Such risk factors are discussed in the Company’s Form SB-2 registration statement (File No. 333-123498), filed with the Securities and Exchange Commission on August 10, 2005, as well as in periodic reports filed with the Commission. There can be no assurance that such factors will not affect the accuracy of such forward-looking statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information set forth in this Press Release including such forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy; nor will there be any sale of securities of Synova Healthcare Group, Inc. in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.
Corporate Contact Information: Synova Healthcare Group, Inc. Attn: Mr. Robert Edwards, CFO 1400 N. Providence Road, Ste. 6010 Media, PA 19063 Tel: 610-565-7080 Fax: 610-565-7081 http://www.synovahealthcare.com Inquiries may also be directed to: info@synovahealthcare.com
Synova Healthcare Group, Inc.
CONTACT: Mr. Robert Edwards, CFO, Synova Healthcare Group, Inc.,+1-610-565-7080, Fax: +1-610-565-7081, info@synovahealthcare.com
Web site: http://www.synovahealthcare.com//
